0Suppliers
2Customers
3Debt Items
20Related Chains

Precipio, Inc. Suppliers

No suppliers on recordPrecipio, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Precipio, Inc. Customers

TickerNameConfidenceEvidence
ONE-CUSTOMER ONE-CUSTOMER 92% At December 31, 2024, one customer accounted for approximately 29% of our total accounts receivable.
THREE-CUSTOMERS THREE-CUSTOMERS 92% At December 31, 2025, we had three customers who each individually represented more than 10% of our total accounts receivable.

Precipio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRPO-DEBT-11904 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
PRPO-DEBT-11903 Warrants outstanding: 10000 90% xbrl warrant detail from xbrl 2026-03-31.
PRPO-DEBT Debt stack $3.7M 90% Market cache reports total debt of $3.7M.

Precipio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Precipio, Inc..

Precipio, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Precipio, Inc..

Precipio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DBVTF DBV TECHNOLOGIES 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2